Table of Contents
Hepatitis Research and Treatment
Volume 2014, Article ID 790753, 5 pages
http://dx.doi.org/10.1155/2014/790753
Research Article

Interleukin-16 Gene Polymorphisms Are Considerable Host Genetic Factors for Patients’ Susceptibility to Chronic Hepatitis B Infection

1Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Department of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, Iran
3Basic and Molecular Epidemiology of Gastroenterology Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Received 21 July 2014; Accepted 13 November 2014; Published 26 November 2014

Academic Editor: Piero Luigi Almasio

Copyright © 2014 Sara Romani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Custer, S. D. Sullivan, T. K. Hazlet et al., “Global epidemiology of hepatitis B virus,” Journal of Clinical Gastroenterology, vol. 38, no. 10, supplement 3, pp. S158–S168, 2004. View at Publisher · View at Google Scholar
  2. A. Wasley, D. Kruszon-Moran, W. Kuhnert et al., “The prevalence of hepatitis B virus infection in the united states in the era of vaccination,” The Journal of Infectious Diseases, vol. 202, no. 2, pp. 192–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Amini, M. F. Mahmoodi, S. Andalibi, and A. Solati, “Seroepidemiology of hepatitis B, Delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study,” The Journal of Tropical Medicine and Hygiene, vol. 96, no. 5, pp. 277–287, 1993. View at Google Scholar · View at Scopus
  4. J. Poorolajal and R. Majdzadeh, “Prevalence of chronic hepatitis B infection in Iran: a review article,” Journal of Research in Medical Sciences, vol. 14, no. 4, pp. 249–258, 2009. View at Google Scholar · View at Scopus
  5. W. W. Cruikshank, D. M. Center, N. Nisar et al., “Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 11, pp. 5109–5113, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Richmond, M. Tuzova, W. Cruikshank, and D. Center, “Regulation of cellular processes by interleukin-16 in homeostasis and cancer,” Journal of Cellular Physiology, vol. 229, no. 2, pp. 139–147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. W. W. Cruikshank, D. M. Center, N. Nisar et al., “Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 11, pp. 5109–5113, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Liu, J. Mills, K. Dixon et al., “IL-16 signaling specifically induces STAT6 activation through CD4,” Cytokine, vol. 38, no. 3, pp. 145–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. J. Chapman and A. V. S. Hill, “Human genetic susceptibility to infectious disease,” Nature Reviews Genetics, vol. 13, no. 3, pp. 175–188, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Kamatani, S. Wattanapokayakit, H. Ochi et al., “A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians,” Nature Genetics, vol. 41, no. 5, pp. 591–595, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Rauch, Z. Kutalik, P. Descombes et al., “Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study,” Gastroenterology, vol. 138, no. 4, pp. 1338–1345, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Urbani, C. Boni, B. Amadei et al., “Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection,” Hepatology, vol. 41, no. 4, pp. 826–831, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. C. Wilson, D. M. Center, and W. W. Cruikshank, “The effect of interleukin-16 and its precursor on T lymphocyte activation and growth,” Growth Factors, vol. 22, no. 2, pp. 97–104, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Sambrook, Molecular Cloning: A Laboratory Manual, edited by J. Sambrook, D. W. Russell, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA, 2001.
  15. L.-B. Gao, L. Rao, Y.-Y. Wang et al., “The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer,” Carcinogenesis, vol. 30, no. 2, pp. 295–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Bannert, K. Vollhardt, B. Asomuddinov et al., “PDZ Domain-mediated interaction of interleukin-16 precursor proteins with myosin phosphatase targeting subunits,” Journal of Biological Chemistry, vol. 278, no. 43, pp. 42190–42199, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. E. A. Lynch, C. A. W. Heijens, N. F. Horst, D. M. Center, and W. W. Cruikshank, “Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5,” The Journal of Immunology, vol. 171, no. 10, pp. 4965–4968, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Bowers, C. Pitcher, and M. Marsh, “CD4: a co-receptor in the immune response and HIV infection,” The International Journal of Biochemistry and Cell Biology, vol. 29, no. 6, pp. 871–875, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Jaruga, F. Hong, R. Sun, S. Radaeva, and B. Gao, “Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes,” The Journal of Immunology, vol. 171, no. 6, pp. 3233–3244, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Durán, A. Rodriguez, P. Martin et al., “Crosstalk between PKCζ and the IL4/Stat6 pathway during T-cell-mediated hepatitis,” EMBO Journal, vol. 23, no. 23, pp. 4595–4605, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Manigold and V. Racanelli, “T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies,” The Lancet Infectious Diseases, vol. 7, no. 12, pp. 804–813, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. H. M. Diepolder, M.-C. Jung, E. Keller et al., “A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B,” Clinical & Experimental Immunology, vol. 113, no. 2, pp. 244–251, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. P. Lim, Y. A. Hsu, K. H. Tsai et al., “The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese,” BMC Immunology, vol. 14, no. 1, article 21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Li, Y. Deng, Z.-P. Chen et al., “Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population,” Infection, Genetics and Evolution, vol. 11, no. 8, pp. 2083–2088, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Azimzadeh, S. Romani, S. R. Mohebbi et al., “Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population,” Cancer Genetics, vol. 205, no. 10, pp. 501–507, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Azimzadeh, S. Romani, S. R. Mohebbi et al., “Interleukin-16 (IL-16) gene polymorphisms in Iranian patients with colorectal cancer,” Journal of Gastrointestinal and Liver Diseases, vol. 20, no. 4, pp. 371–376, 2011. View at Google Scholar · View at Scopus